Artificial Intelligence (AI) at Novartis is powered by some of our top digital talent, our ecosystem of technology and AI partners. Together, we are undertaking an unprecedented leap in discovery for pharma research, life sciences and technology.
As part of our commitment to reimagine medicine, we're using data to help us create transformative medicines that improve people’s lives.
A humbling view – The potential of AI to tackle some of the big challenges for humanity
AI has been around for decades. It was first used in the area of health in 1970, but we’ve entered an age where the volume of data and the speed of computing power have opened up even more possibilities.
What is unique to health in this day and age, is the amount of data we have available to us. The human body is very complex, and while we have successfully sequenced the entire human genome, we still only understand a tiny fraction of human biology.
Over the past two years, Novartis has made substantial progress in our exploration of unchartered areas. In 2017, we launched 12 lighthouse projects, and now, our digital transformation is taking shape. The possibilities are endless.